Page last updated: 2024-11-10

fungichromin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

fungichromin: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID118701617
MeSH IDM0058436

Synonyms (4)

Synonym
14-hydroxyfilipin
(3r,4s,6s,8s,10r,12r,14r,15r,16r,17e,19e,21e,23e,25e,27s,28r)-4,6,8,10,12,14,15,16,27-nonahydroxy-3-[(1r)-1-hydroxyhexyl]-17,28-dimethyl-1-oxacyclooctacosa-17,19,21,23,25-pentaen-2-one
fungichromin
pentamycin

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"The most frequently reported adverse events were mild or moderate vaginal discharge and mild symptoms of vaginal irritation (mainly pruritus or burning sensation), which also occurred in women who applied the vehicle."( Safety, tolerability and pharmacokinetics of intravaginal pentamycin.
Bitzer, J; Drewe, J; Frey Tirri, B; Geudelin, B, 2010
)
0.36
"Intravaginal pentamycin does not cause adverse reactions compared with vehicle and is not absorbed through the intact or the inflamed vagina."( Safety, tolerability and pharmacokinetics of intravaginal pentamycin.
Bitzer, J; Drewe, J; Frey Tirri, B; Geudelin, B, 2010
)
0.36
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (48.00)18.7374
1990's0 (0.00)18.2507
2000's1 (4.00)29.6817
2010's9 (36.00)24.3611
2020's3 (12.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (8.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (92.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]